Only 1 in 5 patients seeking specialist for resistant HBP take meds as prescribed

March 6, 2017, American Heart Association

Only one in five patients seeking specialty care for hard-to-control high blood pressure (resistant hypertension) are taking all their prescribed medications, according to new research in the American Heart Association's journal Hypertension.

"Another twenty percent are not taking any of their medications," said Peter Blankestijn, M.D., Ph.D., senior author of the study and professor of nephrology and hypertension at the University Medical Center Utrecht in the Netherlands. "People mistakenly thought to have resistant hypertension—which is despite taking three or more medications—end up seeing specialists and undergoing extra tests because we don't understand why they are so difficult to treat."

The surprising results come from a study designed primarily to determine if blood pressure can be lowered if people with resistant hypertension receive , in addition to their . In renal denervation, a slim tube (catheter) is inserted into one of the blood vessels in the groin and advanced through blood vessels until it enters the artery feeding the kidney; then, radio waves or ultrasound destroys sections of the nerves sending messages between the brain and the kidneys.

"There is much evidence to suggest that these nerves play a role in high blood pressure. In the 1930s and 1940s, the nerves were sometimes cut during surgical procedures. Now the nerve destruction can be done in a much less invasive way. Several devices are being studied as possible treatments for resistant hypertension," Blankestijn said. "This study, one of the first to look in detail at patient compliance, found renal denervation as therapy for resistant hypertension was not superior to usual care."

Researchers randomly assigned 95 patients (average age 62 years, 42.1 percent male) to undergo renal denervation while not changing their medication, while a control group of 44 patients (average age 60, 29.5 percent male) stayed with their usual medications alone. At the beginning of the study and 6 months later, patients wore a to calculate their average daytime systolic (top number) blood pressure and blood tests were taken to measure drug levels (without telling patients that their adherence in taking recommended medications was being assessed).

Researchers found:

  • 20 percent of patients were taking all their medication and 20 percent none of their medication,
  • 31 percent of patients either improved or lessened their medication compliance.
  • After six months, average daytime systolic blood pressure fell two points (mm Hg) more in control patients than in those who had renal denervation, but remained abnormally high in both groups.
  • Among patients with similar blood levels of medication at each assessment, fell 3.3 points more in those who received the procedure than in controls.

"Adherence to medication greatly affects the ability to assess the value of another treatment, so researchers need to measure adherence and do what they can to improve it," Blankestijn said.

Patients can take steps to prevent their blood pressure from remaining high and being labeled as difficult-to-treat, leading to a greater heart disease risk and increased costs for added tests and treatments.

"At a minimum, be open and honest and tell your physician if you don't want to take your pills for any reason. You and your doctor can discuss options for changing the type of pill or the dose if needed. There are many effective blood pressure pills and the majority of patients with high blood pressure can be successfully treated," Blankestijn said.

Although this study was conducted in the Netherlands, the results likely apply to patients in the United States, according to researchers.

Explore further: Renal denervation achieves significant and sustained blood pressure reduction

More information: Hypertension. DOI: 10.1161/HYPERTENSIONAHA.116.08818

Related Stories

Renal denervation achieves significant and sustained blood pressure reduction

August 27, 2012
Renal denervation leads to significant and sustained blood pressure reduction for up to 18 months in patients with treatment resistant hypertension, according to research presented at ESC Congress 2012. The new clinical data ...

Radio waves to kidneys lower persistent high blood pressure

December 17, 2012
Directing short bursts of radio waves at nerves surrounding the kidneys lowered blood pressure for at least six months and up to one year among patients with hypertension that persists regardless of taking multiple medications ...

Rat study shows that renal denervation helps to bring drug-resistant hypertension under control

February 9, 2016
Up to 10 percent of people with high blood pressure have resistant hypertension—high blood pressure that remains elevated despite treatment with at least three blood pressure medications. Now, researchers report in the ...

Study tests new therapy for treatment-resistant hypertension

June 28, 2012
(Medical Xpress) -- Treatment-resistant hypertension affects nearly 6 million Americans and another 94 million people worldwide and is associated with increased cardiovascular risk, including stroke and heart attack, as well ...

Simple procedure lowers blood pressure in kidney disease patients

May 17, 2012
Disrupting certain nerves in the kidneys can safely and effectively lower blood pressure in patients with chronic kidney disease (CKD) and hypertension, according to a study appearing in an upcoming issue of the Journal of ...

One-year data from SYMPLICITY HTN-3 confirm findings from six month analysis

September 2, 2014
Longer-term follow-up data from the SYMPLICITY HTN-3 trial confirmed both the safety and absence of clinical benefit of renal denervation, according to the 12 month results presented for the first time at ESC Congress today ...

Recommended for you

Antibodies linked to heart attacks

October 23, 2018
Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity, a study from Karolinska Institutet in Sweden published in ...

Poor oral health linked to higher blood pressure, worse blood pressure control

October 22, 2018
People with high blood pressure taking medication for their condition are more likely to benefit from the therapy if they have good oral health, according to new research in the American Heart Association's journal Hypertension.

No sweat required: Team finds hypertension treatment that mimics effect of exercise

October 16, 2018
Couch potatoes rejoice—there might be a way to get the blood pressure lowering benefits of exercise in pill form.

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Why heart contractions are weaker in those with hypertrophic cardiomyopathy

October 16, 2018
When a young athlete suddenly dies of a heart attack, chances are high that they suffer from familial hypertrophic cardiomyopathy (HCM). Itis the most common genetic heart disease in the US and affects an estimated 1 in 500 ...

Novel genetic study sheds new light on risk of heart attack

October 12, 2018
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.